戻る Agenda
SS02: Preparations for Unexpected Infections from the COVID- 19 Pandemic:Rapid Development and Supply of Vaccines and Drugs for Patients
Session Chair(s)
Akiko Ikeda, RPh
PRIMO, External Researcher/Consultant
National Cancer Center, Japan
Mari Ariyasu
Head of Project Management 4, Senior Director
Shionogi & Co., Ltd., Japan
Speaker(s)
Kazuhiro Tateda, MD, PhD
Toho University, Japan
Professor, Department of Microbiology and Infectious Diseases
Noriko Morikubo
Pfizer R&D Japan G.K., Japan
Regulatory Strategy Group2, Japan Regulatory Portfolio Lead
Satoshi Aida
Teijin Pharma Limited, Japan
Chief Planner, Strategic Planning Department